TRDA insider trading — Entrada Therapeutics, Inc.
Over the last 90 days, insiders at Entrada Therapeutics, Inc. (TRDA) made 0 open-market purchases worth $0 and 17 open-market sales worth $5.49M, making them net sellers by $5.49M. The largest sale was by Mpm Bioventures 2014, L.P., Evnin Luke, Gadicke Ansbert, Foley Todd, Mpm Bioventures 2014 (B), L.P., Mpm Asset Management Investors Bv2014 Llc, Mpm Bioventures 2014 Llc, Mpm Bioventures 2014 Gp Llc, Mpm Bioventures 2018 (B), L.P., Mpm Asset Management Investors Bv2018 Llc (10% Owner), who sold 192,500 shares for $1.43M on Sep 8, 2026.
Updated Oct 16, 2026.
Recent TRDA insider transactions
Every Form 4 filed by Entrada Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Mpm Bioventures 2018, L.P., Mpm Bioventures 2018 Llc, Mpm Bioventures 2018 Gp Llc | 10% Owner | S · Sale | Indirect | 28,837 | $7.13 | $206K | Form 4 |
| Sep 8, 2026 | Mpm Bioventures 2018, L.P., Mpm Bioventures 2018 Llc, Mpm Bioventures 2018 Gp Llc | 10% Owner | S · Sale | Indirect | 192,500 | $7.41 | $1.43M | Form 4 |
| Sep 4, 2026 | Mpm Bioventures 2018, L.P., Mpm Bioventures 2018 Llc, Mpm Bioventures 2018 Gp Llc | 10% Owner | S · Sale | Indirect | 38,500 | $7.11 | $274K | Form 4 |
| Sep 9, 2026 | Mpm Bioventures 2014, L.P., Evnin Luke, Gadicke Ansbert, Foley Todd, Mpm Bioventures 2014 (B), L.P., Mpm Asset Management Investors Bv2014 Llc, Mpm Bioventures 2014 Llc, Mpm Bioventures 2014 Gp Llc, Mpm Bioventures 2018 (B), L.P., Mpm Asset Management Investors Bv2018 Llc | 10% Owner | S · Sale | Indirect | 28,837 | $7.13 | $206K | Form 4 |
| Sep 8, 2026 | Mpm Bioventures 2014, L.P., Evnin Luke, Gadicke Ansbert, Foley Todd, Mpm Bioventures 2014 (B), L.P., Mpm Asset Management Investors Bv2014 Llc, Mpm Bioventures 2014 Llc, Mpm Bioventures 2014 Gp Llc, Mpm Bioventures 2018 (B), L.P., Mpm Asset Management Investors Bv2018 Llc | 10% Owner | S · Sale | Indirect | 192,500 | $7.41 | $1.43M | Form 4 |
| Sep 4, 2026 | Mpm Bioventures 2014, L.P., Evnin Luke, Gadicke Ansbert, Foley Todd, Mpm Bioventures 2014 (B), L.P., Mpm Asset Management Investors Bv2014 Llc, Mpm Bioventures 2014 Llc, Mpm Bioventures 2014 Gp Llc, Mpm Bioventures 2018 (B), L.P., Mpm Asset Management Investors Bv2018 Llc | 10% Owner | S · Sale | Indirect | 38,500 | $7.11 | $274K | Form 4 |
| Sep 3, 2026 | Mpm Bioventures 2014, L.P., Evnin Luke, Gadicke Ansbert, Foley Todd, Mpm Bioventures 2014 (B), L.P., Mpm Asset Management Investors Bv2014 Llc, Mpm Bioventures 2014 Llc, Mpm Bioventures 2014 Gp Llc, Mpm Bioventures 2018 (B), L.P., Mpm Asset Management Investors Bv2018 Llc | 10% Owner | S · Sale | Indirect | 32,263 | $7.17 | $231K | Form 4 |
| Sep 3, 2026 | Mpm Bioventures 2018, L.P., Mpm Bioventures 2018 Llc, Mpm Bioventures 2018 Gp Llc | 10% Owner | S · Sale | Indirect | 32,263 | $7.17 | $231K | Form 4 |
| Sep 2, 2026 | Mpm Bioventures 2014, L.P., Evnin Luke, Gadicke Ansbert, Foley Todd, Mpm Bioventures 2014 (B), L.P., Mpm Asset Management Investors Bv2014 Llc, Mpm Bioventures 2014 Llc, Mpm Bioventures 2014 Gp Llc, Mpm Bioventures 2018 (B), L.P., Mpm Asset Management Investors Bv2018 Llc | 10% Owner | S · Sale | Indirect | 25,131 | $7.19 | $181K | Form 4 |
| Sep 2, 2026 | Mpm Bioventures 2018, L.P., Mpm Bioventures 2018 Llc, Mpm Bioventures 2018 Gp Llc | 10% Owner | S · Sale | Indirect | 25,131 | $7.19 | $181K | Form 4 |
| Sep 1, 2026 | Mpm Bioventures 2014, L.P., Evnin Luke, Gadicke Ansbert, Foley Todd, Mpm Bioventures 2014 (B), L.P., Mpm Asset Management Investors Bv2014 Llc, Mpm Bioventures 2014 Llc, Mpm Bioventures 2014 Gp Llc, Mpm Bioventures 2018 (B), L.P., Mpm Asset Management Investors Bv2018 Llc | 10% Owner | S · Sale | Indirect | 29,088 | $7.06 | $205K | Form 4 |
| Sep 1, 2026 | Mpm Bioventures 2018, L.P., Mpm Bioventures 2018 Llc, Mpm Bioventures 2018 Gp Llc | 10% Owner | S · Sale | Indirect | 29,088 | $7.06 | $205K | Form 4 |
| Sep 2, 2026 | Doshi Dipal | CEO | F · Tax withholding | Direct | 8,724 | $7.14 | $62K | Form 4 |
| Sep 2, 2026 | Dowden Nathan J | President & COO | F · Tax withholding | Direct | 2,528 | $7.14 | $18K | Form 4 |
| Sep 2, 2026 | Sethuraman Natarajan | President, Research & Develop. | F · Tax withholding | Direct | 2,079 | $7.14 | $15K | Form 4 |
| Sep 2, 2026 | Wentworth Kory James | Chief Financial Officer | F · Tax withholding | Direct | 1,733 | $7.14 | $12K | Form 4 |
| Aug 31, 2026 | Mpm Bioventures 2018, L.P., Mpm Bioventures 2018 Llc, Mpm Bioventures 2018 Gp Llc | 10% Owner | S · Sale | Indirect | 44,259 | $6.99 | $309K | Form 4 |
| Aug 28, 2026 | Mpm Bioventures 2018, L.P., Mpm Bioventures 2018 Llc, Mpm Bioventures 2018 Gp Llc | 10% Owner | S · Sale | Indirect | 3,733 | $7.01 | $26K | Form 4 |
| Aug 27, 2026 | Mpm Bioventures 2018, L.P., Mpm Bioventures 2018 Llc, Mpm Bioventures 2018 Gp Llc | 10% Owner | S · Sale | Indirect | 38,922 | $7.20 | $280K | Form 4 |
| Aug 31, 2026 | Mpm Bioventures 2014, L.P., Evnin Luke, Gadicke Ansbert, Foley Todd, Mpm Bioventures 2014 (B), L.P., Mpm Asset Management Investors Bv2014 Llc, Mpm Bioventures 2014 Llc, Mpm Bioventures 2014 Gp Llc, Mpm Bioventures 2018 (B), L.P., Mpm Asset Management Investors Bv2018 Llc | 10% Owner | S · Sale | Indirect | 44,259 | $6.99 | $309K | Form 4 |
| Aug 28, 2026 | Mpm Bioventures 2014, L.P., Evnin Luke, Gadicke Ansbert, Foley Todd, Mpm Bioventures 2014 (B), L.P., Mpm Asset Management Investors Bv2014 Llc, Mpm Bioventures 2014 Llc, Mpm Bioventures 2014 Gp Llc, Mpm Bioventures 2018 (B), L.P., Mpm Asset Management Investors Bv2018 Llc | 10% Owner | S · Sale | Indirect | 3,733 | $7.01 | $26K | Form 4 |
| Aug 27, 2026 | Mpm Bioventures 2014, L.P., Evnin Luke, Gadicke Ansbert, Foley Todd, Mpm Bioventures 2014 (B), L.P., Mpm Asset Management Investors Bv2014 Llc, Mpm Bioventures 2014 Llc, Mpm Bioventures 2014 Gp Llc, Mpm Bioventures 2018 (B), L.P., Mpm Asset Management Investors Bv2018 Llc | 10% Owner | S · Sale | Indirect | 38,922 | $7.20 | $280K | Form 4 |
| Aug 26, 2026 | Mpm Bioventures 2014, L.P., Evnin Luke, Gadicke Ansbert, Foley Todd, Mpm Bioventures 2014 (B), L.P., Mpm Asset Management Investors Bv2014 Llc, Mpm Bioventures 2014 Llc, Mpm Bioventures 2014 Gp Llc, Mpm Bioventures 2018 (B), L.P., Mpm Asset Management Investors Bv2018 Llc | 10% Owner | S · Sale | Indirect | 14,569 | $7.06 | $103K | Form 4 |
| Aug 25, 2026 | Mpm Bioventures 2014, L.P., Evnin Luke, Gadicke Ansbert, Foley Todd, Mpm Bioventures 2014 (B), L.P., Mpm Asset Management Investors Bv2014 Llc, Mpm Bioventures 2014 Llc, Mpm Bioventures 2014 Gp Llc, Mpm Bioventures 2018 (B), L.P., Mpm Asset Management Investors Bv2018 Llc | 10% Owner | S · Sale | Indirect | 26,522 | $7.54 | $200K | Form 4 |
| Aug 24, 2026 | Mpm Bioventures 2014, L.P., Evnin Luke, Gadicke Ansbert, Foley Todd, Mpm Bioventures 2014 (B), L.P., Mpm Asset Management Investors Bv2014 Llc, Mpm Bioventures 2014 Llc, Mpm Bioventures 2014 Gp Llc, Mpm Bioventures 2018 (B), L.P., Mpm Asset Management Investors Bv2018 Llc | 10% Owner | S · Sale | Indirect | 21,623 | $7.34 | $159K | Form 4 |
| Aug 26, 2026 | Mpm Bioventures 2018, L.P., Mpm Bioventures 2018 Llc, Mpm Bioventures 2018 Gp Llc | 10% Owner | S · Sale | Indirect | 14,569 | $7.06 | $103K | Form 4 |
| Aug 25, 2026 | Mpm Bioventures 2018, L.P., Mpm Bioventures 2018 Llc, Mpm Bioventures 2018 Gp Llc | 10% Owner | S · Sale | Indirect | 26,522 | $7.54 | $200K | Form 4 |
| Aug 24, 2026 | Mpm Bioventures 2018, L.P., Mpm Bioventures 2018 Llc, Mpm Bioventures 2018 Gp Llc | 10% Owner | S · Sale | Indirect | 21,623 | $7.34 | $159K | Form 4 |
| Aug 10, 2026 | Parmar Kush | Director | S · Sale | Indirect | 92,444 | $7.00 | $647K | Form 4 |
| Aug 7, 2026 | Parmar Kush | Director | S · Sale | Indirect | 52,317 | $6.85 | $358K | Form 4 |
| Aug 6, 2026 | Parmar Kush | Director | S · Sale | Indirect | 10,494 | $7.00 | $73K | Form 4 |
| Aug 7, 2026 | 5Am Ventures V, L.P., 5Am Partners V, Llc, 5Am Opportunities I, L.P., 5Am Opportunities I (Gp), Llc, Rocklage Scott M, Schwab Andrew J. | 10% Owner | S · Sale | Direct | 52,317 | $6.85 | $358K | Form 4 |
| Aug 6, 2026 | 5Am Ventures V, L.P., 5Am Partners V, Llc, 5Am Opportunities I, L.P., 5Am Opportunities I (Gp), Llc, Rocklage Scott M, Schwab Andrew J. | 10% Owner | S · Sale | Direct | 10,494 | $7.00 | $73K | Form 4 |
| Jul 31, 2026 | 5Am Ventures V, L.P., 5Am Partners V, Llc, 5Am Opportunities I, L.P., 5Am Opportunities I (Gp), Llc, Rocklage Scott M, Schwab Andrew J. | 10% Owner | S · Sale | Direct | 1,718 | $6.85 | $12K | Form 4 |
| Jul 30, 2026 | 5Am Ventures V, L.P., 5Am Partners V, Llc, 5Am Opportunities I, L.P., 5Am Opportunities I (Gp), Llc, Rocklage Scott M, Schwab Andrew J. | 10% Owner | S · Sale | Direct | 114,756 | $6.93 | $795K | Form 4 |
| Jul 31, 2026 | Parmar Kush | Director | S · Sale | Indirect | 1,718 | $6.85 | $12K | Form 4 |
| Jul 30, 2026 | Parmar Kush | Director | S · Sale | Indirect | 114,756 | $6.93 | $795K | Form 4 |
TRDA insider trading FAQ
Are insiders buying TRDA stock?
Not on the open market. In the last 90 days, Entrada Therapeutics, Inc. insiders made no open-market purchases, and 17 open-market sales totaling $5.49M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading TRDA?
Recent sellers: Mpm Bioventures 2014, L.P., Evnin Luke, Gadicke Ansbert, Foley Todd, Mpm Bioventures 2014 (B), L.P., Mpm Asset Management Investors Bv2014 Llc, Mpm Bioventures 2014 Llc, Mpm Bioventures 2014 Gp Llc, Mpm Bioventures 2018 (B), L.P., Mpm Asset Management Investors Bv2018 Llc, Parmar Kush.
Where does TRDA insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.